Sapreme Technologies raised €15M in a Series A round in Oct 2021. The company is based in Utrecht, Netherlands. Investors in the round: Aglaia Oncology Funds. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €15M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
